Bericht
Manufacturing for export: A TRIPS-consistent pro-competitive exception
The paper discusses the flexibilization of the sui generis system of supplementary protection certificates (SPCs) under European law recently introduced to allow for the manufacturing, stockpiling and export of covered products. Against this background, it examines the viability under the Agreement on Trade-related Aspects of Intellectual Property Rights (the TRIPS Agreement) of an exception allowing for the manufacture and export of patent-protected products. It concludes that such an exception would promote competition and enhance access to medicines (including biologicals) for the general public while being consistent with Article 30 of the TRIPS Agreement if read in accordance with the principles of interpretation of customary international law.
- Language
-
Englisch
- Bibliographic citation
-
Series: Research Paper ; No. 155
- Classification
-
Sozialwissenschaften, Soziologie, Anthropologie
- Subject
-
Access to Medicines
Biologicals
Competition
Customary International Law
European Law
Exclusive Rights
Export
Health
Intellectual Property
Manufacture
Patent
Sui Generis System
Supplementary Protection Certificates (SPCs)
TRIPS
TRIPS Agreement
World Trade Organization (WTO)
- Event
-
Geistige Schöpfung
- (who)
-
Correa, Carlos María
Correa, Juan I.
- Event
-
Veröffentlichung
- (who)
-
South Centre
- (where)
-
Geneva
- (when)
-
2022
- Handle
- Last update
-
10.03.2025, 11:41 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Bericht
Associated
- Correa, Carlos María
- Correa, Juan I.
- South Centre
Time of origin
- 2022
Other Objects (12)
The Bolar exception: Legislative models and drafting options
Interpreting the flexibilities under the TRIPS agreement
TRIPS flexibilities and TRIPS-plus provisions in the RCEP chapter on intellectual property: How much policy space is retained?
Implementing pro-competitive criteria for the examination of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Policy space for domestic public interest measures under TRIPS
Implementation of TRIPS flexibilities and injunctions: A case study of India
Is the right to use trademarks mandated by the TRIPS Agreement?
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
Lessons from India's implementation of Doha Declaration on TRIPS and Public Health
Non-violation and situation complaints under the TRIPS Agreement: Implications for developing countries
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
The Bolar exception: Legislative models and drafting options
Interpreting the flexibilities under the TRIPS agreement
TRIPS flexibilities and TRIPS-plus provisions in the RCEP chapter on intellectual property: How much policy space is retained?
Implementing pro-competitive criteria for the examination of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Policy space for domestic public interest measures under TRIPS
Implementation of TRIPS flexibilities and injunctions: A case study of India
Is the right to use trademarks mandated by the TRIPS Agreement?
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
Lessons from India's implementation of Doha Declaration on TRIPS and Public Health
Non-violation and situation complaints under the TRIPS Agreement: Implications for developing countries
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
The Bolar exception: Legislative models and drafting options
Interpreting the flexibilities under the TRIPS agreement
TRIPS flexibilities and TRIPS-plus provisions in the RCEP chapter on intellectual property: How much policy space is retained?
Implementing pro-competitive criteria for the examination of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Policy space for domestic public interest measures under TRIPS
Implementation of TRIPS flexibilities and injunctions: A case study of India
Is the right to use trademarks mandated by the TRIPS Agreement?
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
Lessons from India's implementation of Doha Declaration on TRIPS and Public Health
Non-violation and situation complaints under the TRIPS Agreement: Implications for developing countries